Staar Surgical Stock Today
| STAA Stock | USD 26.68 0.05 0.19% |
Performance0 of 100
| Odds Of DistressLess than 1
|
STAAR Surgical is trading at 26.68 as of the 25th of November 2024, a 0.19% up since the beginning of the trading day. The stock's open price was 26.63. STAAR Surgical has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for STAAR Surgical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2022 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 15th of July 1983 | Category Healthcare | Classification Health Care |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. The company has 49.28 M outstanding shares of which 2.92 M shares are at this time shorted by private and institutional investors with about 4.3 trading days to cover. More on STAAR Surgical
Moving together with STAAR Stock
Moving against STAAR Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
STAAR Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Thomas Frinzi | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, Jakarta Stock Exchange, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSTAAR Surgical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand STAAR Surgical's financial leverage. It provides some insight into what part of STAAR Surgical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STAAR Surgical (STAA) is traded on NASDAQ Exchange in USA. It is located in 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630 and employs 1,056 people. STAAR Surgical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.31 B. STAAR Surgical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 49.28 M outstanding shares of which 2.92 M shares are at this time shorted by private and institutional investors with about 4.3 trading days to cover.
STAAR Surgical currently holds about 202.49 M in cash with 14.59 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.22.
Check STAAR Surgical Probability Of Bankruptcy
Ownership AllocationSTAAR Surgical secures a total of 49.28 Million outstanding shares. The majority of STAAR Surgical outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in STAAR Surgical to benefit from reduced commissions. Therefore, outside corporations are subject to a different set of regulations than regular investors in STAAR Surgical. Please pay attention to any change in the institutional holdings of STAAR Surgical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check STAAR Ownership Details
STAAR Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Defender Capital, Llc. | 2024-09-30 | 677.6 K | |
| Northern Trust Corp | 2024-09-30 | 627.8 K | |
| Kayne Anderson Rudnick Investment Management Llc | 2024-06-30 | 592.6 K | |
| Ensign Peak Advisors Inc | 2024-09-30 | 529.2 K | |
| Yunqi Capital Ltd | 2024-09-30 | 515.3 K | |
| American Capital Management Inc | 2024-09-30 | 512.8 K | |
| Armistice Capital, Llc | 2024-09-30 | 496.5 K | |
| Royal Bank Of Canada | 2024-06-30 | 470.1 K | |
| Bank Of America Corp | 2024-06-30 | 460.8 K | |
| Broadwood Capital Inc | 2024-09-30 | 10.8 M | |
| Blackrock Inc | 2024-06-30 | 7.5 M |
STAAR Surgical Historical Income Statement
STAAR Stock Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share 6.962 | Quarterly Revenue Growth 0.103 | Return On Assets 0.0339 |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.